| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
The Second Department of Internal Medicine Kobe University School of Medicine Chuo-ku, Kobe 650, Japan
The adaptor protein Shc contains a phosphotyrosine binding (PTB) domain and a Src homology 2 (SH2) domain, both of which are known to interact with phosphorylated tyrosines. We have shown previously that tyrosine 1148 of the activated epidermal growth factor (EGF) receptor is a major binding site for Shc while tyrosine 1173 is a secondary binding site in intact cells. In the present study, we investigated the interaction between the PTB and SH2 domains of Shc and the activated human EGF receptor. Mutant 52-kDa Shc with an arginine-to-lysine substitution at residue 175 in the PTB domain (Shc R175K) or 397 in the SH2 domain (Shc R397K) was coexpressed in Chinese hamster ovary cells overexpressing the wild-type or mutant EGF receptors that retained only one of the autophosphorylation sites at tyrosine 1148 (QM1148) or 1173 (QM1173). Shc R397K was coprecipitated with the QM1148 and QM1173 receptors, was tyrosine-phosphorylated, and associated with Grb2 and Sos. In contrast, coprecipitation of Shc R175K with the mutant receptors was barely detectable. In cells expressing the QM1173 receptor, Shc R175K was tyrosine-phosphorylated and associated with Grb2, while association of Sos was barely detectable. In cells expressing the QM1148 receptor, tyrosine phosphorylation of Shc R175K was markedly reduced. When both Shc R175K and 46-kDa Shc R397K were coexpressed with the mutant receptors, p46 Shc R397K was dominantly tyrosine-phosphorylated. In cells expressing the wild-type receptor, Shc R397K, but not Shc R175K, translocated to the membrane in an EGF-dependent manner. In addition, Ras activity stimulated by the immunoprecipitates of Shc R397K was significantly higher than that by the immunoprecipitates of Shc R175K. The present results indicate that tyrosine 1148 of the activated EGF receptor mainly interacts with the Shc PTB domain in intact cells. Tyrosine 1173 interacts with both the PTB and SH2 domains, although the interaction with the PTB domain is dominant. In addition, Shc bound to the activated EGF receptor via the PTB domain dominantly interacts with Grb2-Sos complex and plays a major role in the Ras-signaling pathway.
This article has been cited by other articles:
![]() |
N. M. Moss, Y. Liu, J. J. Johnson, P. Debiase, J. Jones, L. G. Hudson, H. G. Munshi, and M. S. Stack Epidermal Growth Factor Receptor-Mediated Membrane Type 1 Matrix Metalloproteinase Endocytosis Regulates the Transition between Invasive versus Expansive Growth of Ovarian Carcinoma Cells in Three-Dimensional Collagen Mol. Cancer Res., June 1, 2009; 7(6): 809 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kamat, P. M. Ghosh, R. L. Glover, B. Zhu, C.-K. Yeh, G. G. Choudhury, and M. S. Katz Reduced Expression of Epidermal Growth Factor Receptors in Rat Liver During Aging J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2008; 63(7): 683 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Cai, J. C. He, L. Zhu, C. Lu, and H. Vlassara Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor PNAS, September 12, 2006; 103(37): 13801 - 13806. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mitsushima, K. Ueda, and N. Kioka Vinexin beta regulates the phosphorylation of epidermal growth factor receptor on the cell surface. Genes Cells, September 1, 2006; 11(9): 971 - 982. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Wilhelmsen, S. H.M. Litjens, and A. Sonnenberg Multiple Functions of the Integrin {alpha}6{beta}4 in Epidermal Homeostasis and Tumorigenesis Mol. Cell. Biol., April 15, 2006; 26(8): 2877 - 2886. [Full Text] [PDF] |
||||
![]() |
I. V. Yosypiv, M. Schroeder, and S. S. El-Dahr Angiotensin II Type 1 Receptor-EGF Receptor Cross-Talk Regulates Ureteric Bud Branching Morphogenesis J. Am. Soc. Nephrol., April 1, 2006; 17(4): 1005 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kasai, T. Shima, and M. Okada Role of Src family tyrosine kinases in the down-regulation of epidermal growth factor signaling in PC12 cells Genes Cells, December 1, 2005; 10(12): 1175 - 1187. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, A. Wolf-Yadlin, P. L. Ross, D. J. Pappin, J. Rush, D. A. Lauffenburger, and F. M. White Time-resolved Mass Spectrometry of Tyrosine Phosphorylation Sites in the Epidermal Growth Factor Receptor Signaling Network Reveals Dynamic Modules Mol. Cell. Proteomics, September 1, 2005; 4(9): 1240 - 1250. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Radtke, S. Haan, A. Jorissen, H. M. Hermanns, S. Diefenbach, T. Smyczek, H. Schmitz-VandeLeur, P. C. Heinrich, I. Behrmann, and C. Haan The Jak1 SH2 Domain Does Not Fulfill a Classical SH2 Function in Jak/STAT Signaling but Plays a Structural Role for Receptor Interaction and Up-regulation of Receptor Surface Expression J. Biol. Chem., July 8, 2005; 280(27): 25760 - 25768. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Dong, S. Ramachandiran, K. Tikoo, Z. Jia, S. S. Lau, and T. J. Monks EGFR-independent activation of p38 MAPK and EGFR-dependent activation of ERK1/2 are required for ROS-induced renal cell death Am J Physiol Renal Physiol, November 1, 2004; 287(5): F1049 - F1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. P. M. Hughes, D. G. Thomas, T. J. Giordano, L. H. Baker, and K. T. McDonagh Cell Surface Expression of Epidermal Growth Factor Receptor and Her-2 with Nuclear Expression of Her-4 in Primary Osteosarcoma Cancer Res., March 15, 2004; 64(6): 2047 - 2053. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Mahajan and H. S. Earp An SH2 Domain-dependent, Phosphotyrosine-independent Interaction between Vav1 and the Mer Receptor Tyrosine Kinase: A MECHANISM FOR LOCALIZING GUANINE NUCLEOTIDE-EXCHANGE FACTOR ACTION J. Biol. Chem., October 24, 2003; 278(43): 42596 - 42603. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ugi, P. M. Sharma, W. Ricketts, T. Imamura, and J. M. Olefsky Phosphatidylinositol 3-Kinase Is Required for Insulin-stimulated Tyrosine Phosphorylation of Shc in 3T3-L1 Adipocytes J. Biol. Chem., May 17, 2002; 277(21): 18592 - 18597. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Hutter, Y. Yo, W. Chen, P. Liu, N. J. Holbrook, G. S. Roth, and Y. Liu Age-Related Decline in Ras/ERK Mitogen-Activated Protein Kinase Cascade Is Linked to a Reduced Association Between Shc and EGF Receptor J. Gerontol. A Biol. Sci. Med. Sci., March 1, 2000; 55(3): 125B - 134. [Abstract] [Full Text] |
||||
![]() |
M. P. Oksvold, E. Skarpen, B. Lindeman, N. Roos, and H. S. Huitfeldt Immunocytochemical Localization of Shc and Activated EGF Receptor in Early Endosomes After EGF Stimulation of HeLa Cells J. Histochem. Cytochem., January 1, 2000; 48(1): 21 - 34. [Abstract] [Full Text] |
||||
![]() |
A. Hashimoto, M. Kurosaki, N. Gotoh, M. Shibuya, and T. Kurosaki Shc Regulates Epidermal Growth Factor-induced Activation of the JNK Signaling Pathway J. Biol. Chem., July 16, 1999; 274(29): 20139 - 20143. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Palmer, C. T. Tuzon, and K. E. Paulson Age-dependent Decline in Mitogenic Stimulation of Hepatocytes. REDUCED ASSOCIATION BETWEEN Shc AND THE EPIDERMAL GROWTH FACTOR RECEPTOR IS COUPLED TO DECREASED ACTIVATION OF Raf AND EXTRACELLULAR SIGNAL-REGULATED KINASES J. Biol. Chem., April 16, 1999; 274(16): 11424 - 11430. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Hermanns, S. Radtke, F. Schaper, P. C. Heinrich, and I. Behrmann Non-redundant Signal Transduction of Interleukin-6-type Cytokines. THE ADAPTER PROTEIN Shc IS SPECIFICALLY RECRUITED TO THE ONCOSTATIN M RECEPTOR J. Biol. Chem., December 22, 2000; 275(52): 40742 - 40748. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Poy, R. J. Ruch, M. A. Fernstrom, Y. Okabayashi, and S. M. Najjar Shc and CEACAM1 Interact to Regulate the Mitogenic Action of Insulin J. Biol. Chem., January 4, 2002; 277(2): 1076 - 1084. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |